Protalix BioTherapeutics’ pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration

2018年2月7日 207 次阅读 0 条评论

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
New User Registration
*Required field